__timestamp | Vericel Corporation | Wave Life Sciences Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 13774000 | 2999000 |
Thursday, January 1, 2015 | 22479000 | 10393000 |
Friday, January 1, 2016 | 27388000 | 15994000 |
Sunday, January 1, 2017 | 35610000 | 26975000 |
Monday, January 1, 2018 | 49007000 | 39509000 |
Tuesday, January 1, 2019 | 61139000 | 48869000 |
Wednesday, January 1, 2020 | 68836000 | 42510000 |
Friday, January 1, 2021 | 97592000 | 46105000 |
Saturday, January 1, 2022 | 106903000 | 50513000 |
Sunday, January 1, 2023 | 120998000 | 51292000 |
Data in motion
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Vericel Corporation and Wave Life Sciences Ltd. from 2014 to 2023. Over this period, Vericel Corporation's SG&A expenses surged by approximately 780%, starting from $13.8 million in 2014 to a staggering $120.9 million in 2023. In contrast, Wave Life Sciences Ltd. experienced a more modest increase of around 1,610%, from $3 million to $51.3 million. This trend highlights Vericel's aggressive expansion strategy, while Wave Life Sciences maintains a more conservative approach. Understanding these financial dynamics offers valuable insights into each company's strategic priorities and market positioning. As the biotech industry continues to evolve, monitoring such financial metrics will be key to predicting future growth trajectories.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: argenx SE vs Vericel Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Analyzing R&D Budgets: Vericel Corporation vs Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends